AI evidence summary · MVP
Creatine for Exercise Recovery
AI research summary · not rated
Research results
Findings are currently provided in Traditional Chinese; source excerpts retain their original language.
Retrieval is incomplete. These results do not represent all relevant research.
Research finding 1
<30 minutes, 24, 48, 72, and 96 hours after exercise13 項隨機對照試驗共 278 名成人的統合結果顯示,補充肌酸相較非肌酸對照,在運動後少於 30 分鐘及 24、48、72、96 小時,均未改變肌力、肌肉痠痛、關節活動範圍或發炎。
此結果限於 20–60 歲成人及運動引起肌肉損傷的恢復情境;來源未報告劑量與劑型。
Relevant to the question; some study details remain unknown. 直接涵蓋成人受試者、肌酸補充與非肌酸對照,以及運動誘發肌肉損傷後的恢復結果;適用範圍限於成人與此類運動情境。
- Population
- 278 adults aged 20–60 years (235 males and 43 females) in 13 randomized controlled trials
- Intervention
- creatine supplementation before and/or after exercise
- Comparator
- noncreatine comparator
- Outcome
- muscle strength, muscle soreness, range of motion, and inflammation
- Follow-up
- <30 minutes, 24, 48, 72, and 96 hours after exercise
- Formulation
- Not established
- Dose
- Not established
Source excerpt: Creatine supplementation did not alter muscle strength, muscle soreness, range of motion, or inflammation at each of the five follow-up times after exercise (<30 min,View source
Research finding 2
48 hours after exercise這項統合分析中,肌酸補充組在運動後 48 小時的肌酸激酶活性較低,標準化平均差為 -1.06(95% 信賴區間 -1.97 至 -0.14)。
其他時間點未見統計上顯著差異,且不同結果與時間點存在高度異質性;肌酸激酶是生物標誌物,不能直接等同運動表現或功能恢復改善。
Relevant to the question; some study details remain unknown. 直接涵蓋成人隨機對照試驗中肌酸對運動誘發肌肉損傷後肌酸激酶的影響,但僅代表一項生物標誌物。
- Population
- 278 adults aged 20–60 years (235 males and 43 females) in 13 randomized controlled trials
- Intervention
- creatine supplementation before and/or after exercise
- Comparator
- noncreatine comparator
- Outcome
- creatine kinase activity
- Follow-up
- 48 hours after exercise
- Formulation
- Not established
- Dose
- Not established
No additional short excerpt is shown for this finding. See the linked source to check the result.
View sourceResearch finding 3
overall; 48, 72, and 96 hours post-exercise9 項運動引起肌肉損傷的隨機對照試驗之合併資料顯示,補充肌酸相較安慰劑可降低整體肌酸激酶濃度(WMD=-30.94,95% CI:-53.19 至 -8.69;p=.006)。
節錄未提供上述濃度差的單位,且在後續三個時間點的結果前截斷;未補述各時間點數值、乳酸脫氫酶結果或缺少的受試者特徵、劑量與劑型。
Relevant to the question; some study details remain unknown. 直接涵蓋肌酸與安慰劑對運動誘發肌肉損傷後生物標誌物的隨機試驗統合結果,但摘要未報告更具體的受試者特徵、劑量或劑型。
- Population
- participants in nine randomized controlled trials following exercise-induced muscle damage
- Intervention
- creatine supplementation
- Comparator
- placebo
- Outcome
- creatine kinase and lactate dehydrogenase concentrations
- Follow-up
- overall; 48, 72, and 96 hours post-exercise
- Formulation
- Not established
- Dose
- Not established
Source excerpt: Pooled data showed that creatine significantly reduced creatine kinase (CK) concentration overall (WMD = -30.94; 95% CI: -53.19, -8.69; p = .006) and at threeView source
What remains unknown
- 引文報告的是 omega-3 對恢復結果的估計與排名,未提供肌酸對恢復結果的獨立效應量,因此與肌酸療效主張不相符。
Sources consulted
- Creatine supplementation effect on recovery following exercise-induced muscle damage: A systematic review and meta-analysis of randomized controlled trials. Abstract only · 2026-09-09T16:19:55.412559Z
- The Effect of Creatine Supplementation on Markers of Exercise-Induced Muscle Damage: A Systematic Review and Meta-Analysis of Human Intervention Trials. Abstract only · 2026-09-09T16:19:55.413559Z
Reading and assessment notes
This AI research summary has not been assigned an overall grade. Learn how summaries and ratings differ.
Absence of reported harms does not establish safety. This summary does not provide individual treatment or dosing advice.
Data and assessment record
Processing record
Search or processing incomplete
Sources through:2026-09-09 · Generated:2026-09-10T03:31:47.476410Z
Retrieved 20 records · Screened 20 · Included 2 reports · Omitted 8
Run:pilot-r1-20260909T161950Z
codex_cli / gpt-5.6-sol / automated-mvp-live-v1
{
"included": 2,
"limits_hit": [
"search_result_window",
"candidates",
"fulltexts",
"fulltext_unavailable"
],
"omitted": 8,
"retrieved": 20,
"screened": 20
} sha256:f76493399c927a08ca36dc9996f03134fca941a5cf6594debac7c5c755d7d995